365 related articles for article (PubMed ID: 18253935)
1. NF-kappaB and epithelial to mesenchymal transition of cancer.
Min C; Eddy SF; Sherr DH; Sonenshein GE
J Cell Biochem; 2008 Jun; 104(3):733-44. PubMed ID: 18253935
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
[TBL] [Abstract][Full Text] [Related]
3. Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.
Wu K; Zeng J; Li L; Fan J; Zhang D; Xue Y; Zhu G; Yang L; Wang X; He D
Oncol Rep; 2010 Jun; 23(6):1545-52. PubMed ID: 20428808
[TBL] [Abstract][Full Text] [Related]
4. High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma.
Bindhu OS; Ramadas K; Sebastian P; Pillai MR
Head Neck; 2006 Oct; 28(10):916-25. PubMed ID: 16823875
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal transition and the invasive potential of tumors.
Gavert N; Ben-Ze'ev A
Trends Mol Med; 2008 May; 14(5):199-209. PubMed ID: 18406208
[TBL] [Abstract][Full Text] [Related]
7. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
[TBL] [Abstract][Full Text] [Related]
8. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition.
Park MY; Kim KR; Park HS; Park BH; Choi HN; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
Int J Oncol; 2007 Dec; 31(6):1309-15. PubMed ID: 17982656
[TBL] [Abstract][Full Text] [Related]
9. [Epithelial-mesenchymal transition in cancer progression].
Gos M; Miłoszewska J; Przybyszewska M
Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
[TBL] [Abstract][Full Text] [Related]
10. A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis.
Vincan E; Brabletz T; Faux MC; Ramsay RG
Cells Tissues Organs; 2007; 185(1-3):20-8. PubMed ID: 17587804
[TBL] [Abstract][Full Text] [Related]
11. Constitutive expression of RbAp46 induces epithelial-mesenchymal transition in mammary epithelial cells.
Li GC; Wang ZY
Anticancer Res; 2006; 26(5A):3555-60. PubMed ID: 17094482
[TBL] [Abstract][Full Text] [Related]
12. Arachidonic acid promotes epithelial-to-mesenchymal-like transition in mammary epithelial cells MCF10A.
Martinez-Orozco R; Navarro-Tito N; Soto-Guzman A; Castro-Sanchez L; Perez Salazar E
Eur J Cell Biol; 2010 Jun; 89(6):476-88. PubMed ID: 20207443
[TBL] [Abstract][Full Text] [Related]
13. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor kappaB.
Oh JH; Kim JH; Ahn HJ; Yoon JH; Yoo SC; Choi DS; Lee IS; Ryu HS; Min CK
Gynecol Oncol; 2009 Sep; 114(3):509-15. PubMed ID: 19539355
[TBL] [Abstract][Full Text] [Related]
15. Modulation of several waves of gene expression during FGF-1 induced epithelial-mesenchymal transition of carcinoma cells.
Billottet C; Tuefferd M; Gentien D; Rapinat A; Thiery JP; Broët P; Jouanneau J
J Cell Biochem; 2008 Jun; 104(3):826-39. PubMed ID: 18189245
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression.
Rosanò L; Spinella F; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Exp Biol Med (Maywood); 2006 Jun; 231(6):1128-31. PubMed ID: 16741062
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB in solid tumors.
Pacifico F; Leonardi A
Biochem Pharmacol; 2006 Oct; 72(9):1142-52. PubMed ID: 16956585
[TBL] [Abstract][Full Text] [Related]
18. NF-κBP65 promotes invasion and metastasis of oesophageal squamous cell cancer by regulating matrix metalloproteinase-9 and epithelial-to-mesenchymal transition.
Wang F; He W; Fanghui P; Wang L; Fan Q
Cell Biol Int; 2013 Aug; 37(8):780-8. PubMed ID: 23504993
[TBL] [Abstract][Full Text] [Related]
19. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.
Kim A; Kim MJ; Yang Y; Kim JW; Yeom YI; Lim JS
Carcinogenesis; 2009 Jun; 30(6):927-36. PubMed ID: 19336468
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB signaling pathway and its therapeutic implications in human diseases.
Sarkar FH; Li Y; Wang Z; Kong D
Int Rev Immunol; 2008; 27(5):293-319. PubMed ID: 18853341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
